Altered regional homogeneity in Parkinson's disease with mild cognitive impairment: a resting-state fMRI study

Xudong Zhu1, Jiaojiao Zhou1, Qiancheng Wei1

  • 1Department of Neurology, Suzhou Hospital of Anhui Medical University, Suzhou, Anhui, China.

Abstract

Insights

This study found altered brain activity patterns in Parkinson's disease with mild cognitive impairment (PD-MCI). Specific brain region ReHo values can help diagnose PD-MCI and monitor its progression.

Area of Science:

  • Neuroimaging
  • Neurology
  • Cognitive Science

Background:

  • Parkinson's disease (PD) is a neurodegenerative disorder.
  • Mild cognitive impairment (MCI) is common in PD patients.
  • Understanding PD-MCI's neurobiological underpinnings is crucial.

Purpose of the Study:

  • To investigate regional homogeneity (ReHo) changes in PD-MCI using rs-fMRI.
  • To correlate ReHo values with cognitive function in PD patients.
  • To identify potential neuroimaging biomarkers for PD-MCI.

Main Methods:

  • Utilized resting-state functional magnetic resonance imaging (rs-fMRI).
  • Compared ReHo in PD-MCI (n=23), PD with normal cognition (PD-NC, n=20), and healthy controls (HC, n=20).
  • Assessed cognitive function using the Montreal Cognitive Assessment (MoCA) and employed ROC curve analysis.

Main Results:

  • PD-MCI showed decreased ReHo in the right middle/superior frontal gyri and increased ReHo in the right cerebellar lobule VIII, left inferior temporal gyrus, and right fusiform gyrus compared to PD-NC.
  • MoCA scores correlated with ReHo in these regions.
  • ROC analysis indicated high diagnostic efficacy (AUC=0.9326) for right cerebellar lobule VIII and left inferior temporal gyrus ReHo in distinguishing PD-MCI from PD-NC.

Conclusions:

  • Functional abnormalities in specific brain regions are linked to PD-MCI development.
  • ReHo in these regions shows potential as neuroimaging biomarkers for PD-MCI diagnosis and monitoring.